Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) — Cash Flow Reinvestment Rate
Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) has a Cash Flow Reinvestment Rate of 0.93x as of September 2025, reinvesting CN¥82.19 Million (capex CN¥82.19 Million ) from operating cash flow of CN¥88.00 Million. Explore capital reinvestment ratio of Guangdong Zhongsheng Pharmaceutical Co L to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Guangdong Zhongsheng Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2006–2024)
Historical reinvestment intensity for Guangdong Zhongsheng Pharmaceutical Co Ltd across 19 annual periods. Also explore 002317 current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Guangdong Zhongsheng Pharmaceutical Co Ltd (2006–2024)
Year-by-year capital reinvestment analysis for Guangdong Zhongsheng Pharmaceutical Co Ltd. For live market cap and broader valuation context, see market value of Guangdong Zhongsheng Pharmaceutical Co L.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.49x | CN¥841.02 Million | CN¥337.84 Million | CN¥228.26 Million | ▼ -57.1% |
| 2023 | 5.80x | CN¥1.11 Billion | CN¥190.61 Million | CN¥363.06 Million | ▼ -33.1% |
| 2022 | 8.67x | CN¥547.02 Million | CN¥63.07 Million | CN¥267.96 Million | ▲ +681.6% |
| 2021 | 1.11x | CN¥691.07 Million | CN¥622.77 Million | CN¥213.76 Million | ▼ -47.2% |
| 2020 | 2.10x | CN¥291.87 Million | CN¥138.93 Million | CN¥154.43 Million | ▲ +100.4% |
| 2019 | 1.05x | CN¥263.23 Million | CN¥251.16 Million | CN¥128.33 Million | ▼ -3.4% |
| 2018 | 1.08x | CN¥354.39 Million | CN¥326.78 Million | CN¥143.48 Million | ▼ -29.3% |
| 2017 | 1.53x | CN¥567.68 Million | CN¥369.91 Million | CN¥124.28 Million | ▼ -38.1% |
| 2016 | 2.48x | CN¥838.45 Million | CN¥338.28 Million | CN¥141.19 Million | ▼ -12.1% |
| 2015 | 2.82x | CN¥542.27 Million | CN¥192.25 Million | CN¥76.57 Million | ▲ +42.2% |
| 2014 | 1.98x | CN¥199.54 Million | CN¥100.60 Million | CN¥199.54 Million | ▲ +96.7% |
| 2013 | 1.01x | CN¥111.91 Million | CN¥110.95 Million | CN¥111.91 Million | ▲ +85.5% |
| 2012 | 0.54x | CN¥77.42 Million | CN¥142.38 Million | CN¥77.42 Million | ▼ -79.3% |
| 2011 | 2.63x | CN¥185.41 Million | CN¥70.56 Million | CN¥185.41 Million | ▲ +259.6% |
| 2010 | 0.73x | CN¥67.02 Million | CN¥91.72 Million | CN¥67.02 Million | ▲ +222.9% |
| 2009 | 0.23x | CN¥22.83 Million | CN¥100.89 Million | CN¥22.83 Million | ▼ -15.4% |
| 2008 | 0.27x | CN¥19.49 Million | CN¥72.86 Million | CN¥19.49 Million | ▼ -48.6% |
| 2007 | 0.52x | CN¥25.67 Million | CN¥49.35 Million | CN¥25.67 Million | ▼ -5.4% |
| 2006 | 0.55x | CN¥9.84 Million | CN¥17.91 Million | CN¥9.84 Million | — |